{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:06:03Z","timestamp":1793862363408,"version":"4.6.1"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Acute kidney injury (AKI) after cardiac surgery is associated with increased morbidity and mortality, and measures to prevent AKI have had limited success. Glutamate has been reported to enhance natural postischemic recovery of the heart, but not among animals and humans with diabetes.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To summarize pooled results from the GLUTAMICS (Glutamate for Metabolic Intervention in Coronary Surgery) trials regarding the effect of glutamate on postoperative AKI among patients without diabetes undergoing coronary artery bypass graft (CABG) surgery.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n Data on a total of 791 patients without diabetes from 2 prospective, randomized, double-blind multicenter trials performed at 5 cardiac surgery centers in Sweden between October 4, 2005, and November 12, 2009, and between November 15, 2015, and September 30, 2020, were pooled. Patients had acute coronary syndrome, left ventricular ejection fraction of 0.30 or less, or a European System for Cardiac Risk Evaluation II score of 3.0 or more and underwent CABG with or without additional valve procedure. Statistical analysis was performed from May to November 2023.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n \n Intravenous infusion of 0.125-M\n l<\/jats:sc>\n -glutamic acid or saline at 1.65 mL\/kg\/h for 2 hours during reperfusion, after which the infusion rate was halved and an additional 50 mL was given.\n <\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary end point was AKI, defined as postoperative increase of plasma creatinine of 50% or more, corresponding to the Risk stage or higher in the Risk, Injury, Failure, Loss, and End-Stage kidney disease (RIFLE) criteria.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 791 patients without diabetes (391 who received glutamate [mean (SD) age, 69.3 (9.1) years; 62 women (15.9%)] and 400 controls [mean (SD) age, 69.6 (9.5) years; 73 women (18.3%)]) were randomized. Baseline data did not differ between groups. Glutamate was associated with a significantly lower risk of AKI (relative risk, 0.49 [95% CI, 0.29-0.83]). Dialysis was required for 2 patients in the glutamate group and 5 patients in the control group. In multivariable analysis, glutamate remained significantly associated with a protective effect against AKI (odds ratio, 0.47 [95% CI, 0.26-0.86]). In the glutamate and control groups, the rate of postoperative mortality at 30 days or less was 0.5% (2 of 391) vs 1.0% (4 of 400), and the rate of stroke at 24 hours or less was 0.8% (3 of 391) vs 1.8% (7 of 400).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this pooled analysis of 2 randomized clinical trials, infusion of glutamate was associated with a markedly lower risk of AKI after CABG among patients without diabetes. The findings are exploratory and need to be confirmed in prospective trials.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifiers:\n NCT00489827<\/jats:ext-link>\n and\n NCT02592824<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.51743","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T11:32:04Z","timestamp":1705923124000},"page":"e2351743","source":"Crossref","is-referenced-by-count":19,"title":["Association of Glutamate Infusion With Risk of Acute Kidney Injury After Coronary Artery Bypass Surgery"],"prefix":"10.1001","volume":"7","author":[{"given":"Jonas","family":"Holm","sequence":"first","affiliation":[{"name":"Department of Thoracic and Vascular Surgery, Department of Health, Medicine and Caring Sciences, Unit of Cardiovascular Medicine, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farkas","family":"Vanky","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Vascular Surgery, Department of Health, Medicine and Caring Sciences, Unit of Cardiovascular Medicine, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Svedjeholm","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Vascular Surgery, Department of Health, Medicine and Caring Sciences, Unit of Cardiovascular Medicine, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"issue":"4","key":"zoi231518r1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/1089253215593177","article-title":"Acute kidney injury in cardiac surgery and cardiac intensive care.","volume":"19","author":"Lau","year":"2015","journal-title":"Semin Cardiothorac Vasc Anesth"},{"issue":"3","key":"zoi231518r2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2215\/CJN.07830814","article-title":"AKI associated with cardiac surgery.","volume":"10","author":"Thiele","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"zoi231518r3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jtcvs.2013.07.073","article-title":"Incidence, dynamics, and prognostic value of acute kidney injury for death after cardiac surgery.","volume":"147","author":"Dardashti","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"zoi231518r4","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.athoracsur.2005.07.047","article-title":"Acute renal failure after cardiac surgery: evaluation of the RIFLE classification.","volume":"81","author":"Kuitunen","year":"2006","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"zoi231518r5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jtcvs.2019.11.137","article-title":"The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients.","volume":"162","author":"Priyanka","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"zoi231518r6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/CCM.0b013e318169181a","article-title":"Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure?","volume":"36","author":"Lassnigg","year":"2008","journal-title":"Crit Care Med"},{"issue":"10","key":"zoi231518r7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1001\/jama.2022.1823","article-title":"Predictive models for acute kidney injury following cardiac surgery: the importance of accurate and actionable prediction.","volume":"327","author":"Ostermann","year":"2022","journal-title":"JAMA"},{"issue":"9","key":"zoi231518r8","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1053\/j.jvca.2023.05.032","article-title":"Adult cardiac surgery\u2013associated acute kidney injury: joint consensus report.","volume":"37","author":"Brown","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"6","key":"zoi231518r9","doi-asserted-by":"publisher","first-page":"H873","DOI":"10.1152\/ajpheart.1979.236.6.H873","article-title":"Enhanced mechanical recovery of anoxic and ischemic myocardium by amino acid perfusion.","volume":"236","author":"Rau","year":"1979","journal-title":"Am J Physiol"},{"issue":"8","key":"zoi231518r10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1440-1681.1996.tb01748.x","article-title":"Mechanisms of myocardial protection by amino acids: facts and hypotheses.","volume":"23","author":"Pisarenko","year":"1996","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"zoi231518r11","doi-asserted-by":"publisher","first-page":"E461","DOI":"10.1152\/ajpendo.1978.235.5.E461","article-title":"Amino acid stimulation of oxygen and substrate utilization by cardiac myocytes.","volume":"235","author":"Burns","year":"1978","journal-title":"Am J Physiol"},{"issue":"2","key":"zoi231518r12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0885-4505(89)90046-7","article-title":"Association of myocardial glutamate and aspartate pool and functional recovery of postischemic heart.","volume":"42","author":"Pisarenko","year":"1989","journal-title":"Biochem Med Metab Biol"},{"issue":"3","key":"zoi231518r13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0022-5223(19)37760-8","article-title":"Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion.","volume":"80","author":"Lazar","year":"1980","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"zoi231518r14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0022-5223(19)36656-5","article-title":"Reduction of infarct size by systemic amino acid supplementation during reperfusion.","volume":"101","author":"Engelman","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"zoi231518r15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/ejcts\/ezu366","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS): developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).","volume":"46","author":"Kolh","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"zoi231518r16","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1172\/JCI108571","article-title":"Alterations of myocardial amino acid metabolism in chronic ischemic heart disease.","volume":"58","author":"Mudge","year":"1976","journal-title":"J Clin Invest"},{"issue":"1","key":"zoi231518r17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/cs0640033","article-title":"Myocardial exchanges of glutamate, alanine and citrate in controls and patients with coronary artery disease.","volume":"64","author":"Thomassen","year":"1983","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"zoi231518r18","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0022-5223(19)36700-5","article-title":"Myocardial uptake of amino acids and other substrates in relation to myocardial oxygen consumption four hours after cardiac operations.","volume":"101","author":"Svedjeholm","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"zoi231518r19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1042\/cs0700007","article-title":"Cardiac metabolism and performance during l-glutamic acid infusion in postoperative cardiac failure.","volume":"70","author":"Pisarenko","year":"1986","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"zoi231518r20","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/S0022-5223(96)70005-3","article-title":"Metabolic and hemodynamic effects of intravenous glutamate infusion early after coronary operations.","volume":"112","author":"Svedjeholm","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"zoi231518r21","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jtcvs.2012.05.066","article-title":"GLUTAMICS\u2014a randomized clinical trial on glutamate infusion in 861 patients undergoing surgery for acute coronary syndrome.","volume":"144","author":"Vidlund","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"zoi231518r22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003997","article-title":"Effect of glutamate infusion on NT-proBNP after coronary artery bypass grafting in high-risk patients (GLUTAMICS II): a randomized controlled trial.","volume":"19","author":"Holm","year":"2022","journal-title":"PLoS Med"},{"issue":"9","key":"zoi231518r23","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/j.1440-1681.2009.05166.x","article-title":"Cardioprotective effect of l-glutamate in obese type 2 diabetic Zucker fatty rats.","volume":"36","author":"Povlsen","year":"2009","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"20","key":"zoi231518r24","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.jacc.2009.07.031","article-title":"Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart.","volume":"54","author":"Anderson","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"zoi231518r25","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"zoi231518r26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/14017439850140102","article-title":"Assessment of myocardial glutamate requirements early after coronary artery bypass surgery.","volume":"32","author":"Vanhanen","year":"1998","journal-title":"Scand Cardiovasc J"},{"issue":"1","key":"zoi231518r27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/14017430903531008","article-title":"A metabolic protective strategy could improve long-term survival in patients with LV-dysfunction undergoing CABG.","volume":"44","author":"Svedjeholm","year":"2010","journal-title":"Scand Cardiovasc J"},{"issue":"1","key":"zoi231518r29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12871-016-0216-z","article-title":"Post hoc analysis of the GLUTAMICS\u2013trial: intravenous glutamate infusion and use of inotropic drugs after CABG.","volume":"16","author":"Vidlund","year":"2016","journal-title":"BMC Anesthesiol"},{"issue":"2","key":"zoi231518r30","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/0003-4975(94)00918-W","article-title":"Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations.","volume":"59","author":"Svedjeholm","year":"1995","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"zoi231518r31","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/aas.14303","article-title":"Glutamate infusion associated with reduced rises of p-copeptin after coronary surgery: substudy of GLUTAMICS II.","volume":"67","author":"Svedjeholm","year":"2023","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"zoi231518r32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/eci.12234","article-title":"Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.","volume":"44","author":"Takase","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"zoi231518r33","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1111\/j.1751-7133.2010.00177.x","article-title":"Copeptin: a biomarker of cardiovascular and renal function.","volume":"16","author":"Morgenthaler","year":"2010","journal-title":"Congest Heart Fail"},{"key":"zoi231518r34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1752-0509-7-110","article-title":"A combinatorial approach of proteomics and systems biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI.","volume":"7","author":"Husi","year":"2013","journal-title":"BMC Syst Biol"},{"issue":"2","key":"zoi231518r35","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jss.2013.01.040","article-title":"Effect of modulating the allosteric sites of N-methyl-d-aspartate receptors in ischemia-reperfusion induced acute kidney injury.","volume":"183","author":"Pundir","year":"2013","journal-title":"J Surg Res"},{"issue":"2","key":"zoi231518r36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.biopha.2005.07.012","article-title":"Monosodium glutamate\u2013induced damage in liver and kidney: a morphological and biochemical approach.","volume":"60","author":"Ortiz","year":"2006","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"zoi231518r37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2007-1013981","article-title":"Trauma metabolism and the heart: studies of heart and leg amino acid flux after cardiac surgery.","volume":"38","author":"Svedjeholm","year":"1990","journal-title":"Thorac Cardiovasc Surg"},{"issue":"1","key":"zoi231518r38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/MCO.0000000000000339","article-title":"Glutamine and the regulation of intestinal permeability: from bench to bedside.","volume":"20","author":"Achamrah","year":"2017","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"11","key":"zoi231518r39","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/nu10111564","article-title":"Glutamine: metabolism and immune function, supplementation and clinical translation.","volume":"10","author":"Cruzat","year":"2018","journal-title":"Nutrients"},{"issue":"9","key":"zoi231518r40","doi-asserted-by":"publisher","first-page":"S545","DOI":"10.1097\/01.CCM.0000279193.23737.06","article-title":"Exogenous glutamine: the clinical evidence.","volume":"35","author":"Bongers","year":"2007","journal-title":"Crit Care Med"},{"issue":"6","key":"zoi231518r41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1042\/cs1010573","article-title":"The effect of glutamate infusion on cardiac performance is independent of changes in metabolism in patients undergoing routine coronary artery bypass surgery.","volume":"101","author":"Langenberg","year":"2001","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"zoi231518r42","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1010-7940(99)00287-0","article-title":"Routine SvO2 measurement after CABG surgery with a surgically introduced pulmonary artery catheter.","volume":"16","author":"Svedjeholm","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"issue":"10","key":"zoi231518r43","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/0278-6915(85)90103-6","article-title":"Correlation of glutamate plus aspartate dose, plasma amino acid concentration and neuronal necrosis in infant mice.","volume":"23","author":"Daabees","year":"1985","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"zoi231518r44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.clnu.2009.09.007","article-title":"The S-100B substudy of the GLUTAMICS trial: glutamate infusion not associated with sustained elevation of plasma S-100B after coronary surgery.","volume":"29","author":"Vidlund","year":"2010","journal-title":"Clin Nutr"},{"issue":"1","key":"zoi231518r45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12882-017-0487-8","article-title":"Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria.","volume":"18","author":"Koeze","year":"2017","journal-title":"BMC Nephrol"},{"key":"zoi231518r28","unstructured":"Apoteket Produktion & Laboratorier. Accessed December 5, 2023. https:\/\/www.apl.se\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2814119\/holm_2024_oi_231518_1772649077.73788.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T19:00:23Z","timestamp":1772650823000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2814119"}},"subtitle":["A Pooled Analysis of 2 Randomized Clinical Trials"],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.51743","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]}}}